Gene expression in human peripheral blood mononuclear cells upon acute ischemic stroke (original) (raw)

References

  1. Baird AE (2007) Blood genomics in human stroke. Stroke 38:694–698
    Article PubMed CAS Google Scholar
  2. Bakay M, Chen YW, Borup R, Zhao P, Nagaraju K, Hoffman EP (2002) Sources of variability and effect of experimental approach on expression profiling data interpretation. BMC Bioinformatics 3:4
    Article PubMed Google Scholar
  3. Barnum SR, Ames RS, Maycox PR, Hadingham SJ, Meakin J, Harrison D, Parsons AA (2002) Expression of the complement C3a and C5a receptors after permanent focal ischemia: An alternative interpretation. Glia 38:169–173
    Article PubMed Google Scholar
  4. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series, pp 289–300
    Google Scholar
  5. Chiang N, Serhan CN, Dahlen SE, Drazen JM, Hay DWP, Rovati GE, Shimizu T, Yokomitz T, Brink C (2006) The lipoxin receptor ALX: Potent ligandspecific and steroselective actions in vivo. Pharmacol Rev 58:463–487
    Article PubMed CAS Google Scholar
  6. Chtanova T, Newton R, Liu SM, Weininger L, Young TR, Silva DG, Bertoni F, Rinaldi A, Chappaz S, Sallusto F, Rolph MS, Mackay CR (2005) Identification of T cell-restricted genes and signatures for different T cell responses, using a comprehensive collection of microarray datasets. J Immunol 175:7837–7847
    PubMed CAS Google Scholar
  7. Connolly PH, Caiozzo VJ, Zaldivar F, Nemet D, Larson J, Hung SP, Heck JD, Hatfield GW, Cooper DM (2004) Effects of exercise on gene expression in human peripheral blood mononuclear cells. J Appl Physiol 97:1461–1469
    Article PubMed CAS Google Scholar
  8. Cowell RM, Plane JM, Silverstein FS (2003) Complement activation contributes to hypoxic ischemic brain injury in neonatal rats. J. Neurosci 23:9459–9468
    PubMed Google Scholar
  9. Emsley HC, Smith CJ, Georgiou RF, Vail A, Hopkins SJ, Rothwell NJ, Tyrell PJ, acute stroke investigators (2005) A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry 76:1366–1372
    Article PubMed CAS Google Scholar
  10. Feezor RJ, Baker HV, Mindrinos M, Hayden D, Tannahill CL, Brownstein BH, Fay A, MacMillan S, Laramie J, Xiao W, Moldawer LL, Cobb JP, Laudanski K, Miller-Graziano CL, Maier RV, Schoenfeld D, Davis RW, Tompkins RG; and the Inflammation and Host Response to Injury, Large-Scale Collaborative Research Program (2004) Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol Genomics 19:247– 254
    Article PubMed CAS Google Scholar
  11. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80
    Article PubMed Google Scholar
  12. Gretarsdottir S, Sveinbjornsdottir S, Jonsson HH, Jakobsson F, Einarsdottir E, Agnarsson U, Shkolny D, Einarsson G, Gudjonsdottir HM, Valdimarsson EM, Einarsson OB, Thorgeirsson G, Hadzic R, Jonsdottir S, Reynisdottir ST, Bjarnadottir SM, Gudmundsdottir T, Gudlaugsdottir GJ, Gill R, Lindpaintner K, Sainz J, Hannesson HH, Sigurdsson GT, Frigge ML, Kong A, Gudnason V, Stefansson K, Gulcher JR (2002) Localization of a susceptibility gene for common forms of stroke to 5q12. Am J Hum Genet 70:593–603
    Article PubMed CAS Google Scholar
  13. Gretarsdottir S, Thorleifsson G, Reynisdottir ST, Manolescu A, Jonsdottir S, Jonsdottir T, Gudmundsdottir T, Bjarnadottir SM, Einarsson OB, Gudjonsdottir HM, Hawkins M, Gudmundsson G, Gudmundsdottir H, Andrason H, Gudmundsdottir AS, Sigurdardottir M, Chou TT, Nahmias J, Goss S, Sveinbjornsdottir S, Valdimarsson EM, Jakobsson F, Agnarsson U, Gudnason V, Thorgeirsson G, Fingerle J, Gurney M, Gudbjartsson D, Frigge ML, Kong A, Stefansson K, Gulcher JR (2003) The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Gen 353:131–138
    Article Google Scholar
  14. Grond-Ginsbach C, Horstmann S, Hummel M, Wiest T, Honold C, Pfleger K, Hergenhahn M, Hollstein M, Weninger A, Knyazev Y, Mansmann U, Grau AJ, Wagner S (2007) Gene expression in peripheral blood mononuclear cells (PBMCs) from stroke survivors. (Manuscript submitted)
  15. Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, Samani NJ, Gudmundsson G, Grant SF, Thorgeirsson G, Sveinbjornsdottir S, Valdimarsson EM, Matthiasson SE, Johannsson H, Gudmundsdottir O, Gurney ME, Sainz J, Thorhallsdottir M, Andresdottir M, Frigge ML, Topol EJ, Kong A, Gudnason V, Hakonarson H, Gulcher JR, Stefansson K (2004) The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36:233–239
    Article PubMed CAS Google Scholar
  16. Iaonnidis JPA (2005) Why most published research findings are false. PLoS Medicine 2:696–701
    Google Scholar
  17. Jolly RA, Goldstein KM, Wei T, Gao H, Chen P, Huang S, Colet JM, Ryan TP, Thomas CE, Estrem ST (2005) Pooling samples within microarray studies: a comparative analysis of rat liver transcription response to prototypical toxicants. Physiol Genomics 22:346–355
    Article PubMed CAS Google Scholar
  18. Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez MV, Kitrell FS, Zahnow CA, Patterson N, Golub TR, Ewen ME (2003) A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114:323–334
    Article PubMed CAS Google Scholar
  19. Liu J, Walter E, Stenger D, Thach D (2006) Effects of globin mRNA reduction methods on gene expression profiles from whole blood. J Mol Diagnos 8:551–558
    Article CAS Google Scholar
  20. Malcolm KC, Arndt PG, Manos EJ, Jones DA, Worthen GS (2003) Microarray analysis of lipopolysaccharidetreated human neutrophils. Am J Physiol 284:L663–L670
    CAS Google Scholar
  21. Mansmann U, Meister R (2005) Testing differential gene expression in functional groups. Goeman’s global test versus an ANCOVA approach. Methods Inf Med 44:449–453
    PubMed CAS Google Scholar
  22. Mocco J, Mack WJ, Ducruet AF, Susonov SA, Sughrue ME, Hassid BG, Nair MN, Laufer I, Komotar RJ, Claire M, Holland H, Pinsky DJ, Connolly ES (2006) Complement factor. Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circulation Res 99:209–217
    Article PubMed CAS Google Scholar
  23. Moore DF, Li H, Jeffries N, Wright V, Cooper RA, Elkahloun A, Gelderman MP, Zudaire E, Blevins G, Yu H, Goldin E, Baird AE (2005) Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation. Circulation 111:212–221
    Article PubMed CAS Google Scholar
  24. Rosand J, Bayley N, Rost N, de Bakker PI (2006) Many hypotheses but no replication for the association between PDE4D and stroke. Nature Genetics 38:1091–1092
    Article PubMed CAS Google Scholar
  25. Rothwell N, Allan S, Toulmond S (1997) The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J Clin Invest 100:2648–2652
    Article PubMed CAS Google Scholar
  26. Sebastiani P, Ramoni MF, Nolan V, Baldwin CT, Steinberg MH (2005) Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nature Genetics 37:435–440
    Article PubMed CAS Google Scholar
  27. Sharp FR, Lit L, Xu H, Apperson M, Walker W, Wong B, Gilbert DL, Hershey G, Glauser TA (2006) Genomics of brain and blood: progress and pitfalls. Epilepsia 47:1603–1607
    Article PubMed CAS Google Scholar
  28. Sharp FR, XU H, Lit L, Walker W, Pinter J, Apperson M, Verro P (2007) Genomic profiles of stroke in blood. Stroke 38:691–693
    Article PubMed Google Scholar
  29. Subrahmanyam Y, Yamaga S, Prashar Y, Lee HH, Hoe NP, Kluger Y, Gerstein M, Goguen JD, Newburger PE, Weissman SM (2001) RNA expression patterns change dramatically in human neutrophils exposed to bacteria. Blood 97:2457–2468
    Article PubMed CAS Google Scholar
  30. Tang Y, Xu H, Du X, Lit L, Walker W, Lu A, Ran R, Gregg JP, Reilly M, Pancioli A, Khoury JC, Sauerbeck LR, Carrozzella JA, Spilker J, Clark J, Wagner KR, Jauch EC, Chang DJ, Verro P, Broderick JP, Sharp FR (2006) Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab 26:1089–1102
    Article PubMed CAS Google Scholar
  31. Wang Y, Chang CF, Morales M, Chou J, Chen HL, Chiang YH, Lin SZ, Cadet J, Deng X, Wang JY, Chen SY, Kaplan PL, Hoffer BJ (2001) Bone morphogenetic protein-6 reduces ischemia-induced brain damage in rats. Stroke 32:2170– 2178
    Article PubMed CAS Google Scholar
  32. Worrall BB, Brott TG, Brown RD, Brown WM, Rich SS, Arepalli S, Wavrant-De Vrièze F, Duckworth J, Singleton AB, Hardy J, Meschia JF (2007) IL1RN VNTR polymorphism in ischemic stroke: analysis in 3 populations. Stroke 38:1189–1196
    Article PubMed CAS Google Scholar
  33. Wu Z, Irizarry RA, Gentleman R, Martinez Murillo F, Spencer F (2004) A Model Based Background Adjustment for Oligonucleotide Expression Arrays. J Am Statist Assoc 99:909–917
    Article Google Scholar
  34. Yue L, Reisdorf WC (2005) Pathway and ontology analysis: emerging approaches connecting transcriptome data and clinical endpoints. Curr Mol Med 5:11–21
    Article PubMed CAS Google Scholar
  35. Zakharkin OS, Kim K, Mehta T, Chen L, Barnes S, Scheirer KE, Parrish RS, Allison DB, Page GP (2005) Sources of variation in Affymetrix microarray experiments. BMC Bioinformatics 6:214
    Article PubMed Google Scholar

Download references